Physician

Eugene Mitchell Long, M.D.

According to 2025 Medicare claims, Eugene Long, M.D. (NPI: 1477996965) practices internal medicine in the Augusta-Richmond County, GA-SC market, with the plurality of this provider's patient population coming from Aiken, SC. This provider's primary affiliated billing organization is AUGUSTA ONCOLOGY ASSOCIATES, P.C. (NPI: 1871147454) and primary practice location at 29841-3862.

Long's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 777 traditional Medicare patients, billed 226,535 HCPCS/CPT codes, and received $3,534,288 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,568 prescription claims across 306 beneficiaries totaling $4,782,279 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 71 claims. Open Payments data shows 218 records totaling $6,825. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $215,713 to $3,534,288. Similarly, Part D prescription costs have moved sharply higher in recent years, from $5,923 to $4,782,279. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	124	19,251	$215,713
2020	396	74,039	$1,157,092
2021	609	166,354	$2,019,729
2022	756	235,482	$2,837,806
2023	801	237,884	$3,638,078
2024	777	226,535	$3,534,288

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	33	120	$5,923
2016	50	202	$12,498
2017	48	141	$29,277
2018	42	141	$34,672
2019	60	197	$96,278
2020	194	875	$2,078,084
2021	228	1,056	$1,896,550
2022	265	1,335	$2,746,360
2023	298	1,504	$3,453,079
2024	306	1,568	$4,782,279

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	66	$2,802
2023	N/R	73	$3,401
2024	N/R	71	$3,412

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	241	565	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	171	226	$58
80053	Blood test, comprehensive group of blood chemicals	531	1,371	$10
36415	Insertion of needle into vein for collection of blood sample	611	1,716	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	576	1,661	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	63	1,576	$769,377
Xtandi	Enzalutamide	55	1,650	$734,321
Imbruvica	Ibrutinib	32	908	$523,653
Tagrisso	Osimertinib Mesylate	19	570	$309,311
Erleada	Apalutamide	20	600	$299,548

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	36	$2,431
J8521	Capecitabine, oral, 500 mg	N	N/R	11	$614
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	24	$367

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	218	$6,825	Novocure Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Eugene Mitchell Long, M.D.?

Tedicare shows public-source Medicare data for Eugene Mitchell Long, M.D. (NPI 1477996965), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eugene Mitchell Long, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Eugene Mitchell Long, M.D.?

Eugene Mitchell Long, M.D. is linked to AUGUSTA ONCOLOGY ASSOCIATES, P.C. (billing NPI 1871147454) in the available physician profile data.

Does Eugene Mitchell Long, M.D. have Open Payments data?

Eugene Mitchell Long, M.D. has 218 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.